Donald E. Ingber is Founding Director at Wyss Institute for Biologically Inspired Engineering at Harvard University, Professor of Vascular Biology, and Professor of Bioengineering at Harvard University. His work breaks down boundaries between science, art, and design. In this keynote lecture, he will talk about his work on human Organ Chips -which offer the possibility of replacing animal testing and advancing personalized medicine – and how Biologically Inspired Engineering could solve some of the world's greatest challenges in medicine and the environment.
Donald E. Ingber will share his path from a serendipitous experience in an undergraduate art class that led to his discovery of how living cells are constructed using 'tensegrity' architecture to his more recent work on human Organ Chips - which offer the possibility of replacing animal testing and advancing personalized medicine. He also will describe the burgeoning discipline of Biologically Inspired Engineering and the Institute he founded to develop bioinspired technologies to solve some of the world's greatest challenges in medicine and the environment. The work he will describe breaks down boundaries between science, engineering, art, and design and demonstrates that there are no boundaries to creativity.
Donald E. Ingber
Donald E. Ingber, M.D., Ph.D. is the Founding Director of the Wyss Institute for Biologically Inspired Engineering at Harvard University, Judah Folkman Professor of Vascular Biology at Harvard Medical School and the Vascular Biology Program at Boston Children's Hospital, and Professor of Bioengineering at the Harvard John A. Paulson School of Engineering and Applied Sciences. He received his B.A., M.A., M.Phil., M.D., and Ph.D. from Yale University. Ingber is a pioneer in the field of biologically inspired engineering. At the Wyss Institute, he currently leads a multifaceted effort to develop breakthrough bioinspired technologies to advance healthcare and improve sustainability. His work has led to major advances in mechanobiology, tumor angiogenesis, tissue engineering, systems biology, nanobiotechnology, and translational medicine. Through his work, Ingber has also helped break down boundaries between science, art, and design. Ingber has authored more than 500 publications and over 135 issued or pending patents, founded five companies, and has been a guest speaker at more than 550 events internationally. He is a member of the National Academy of Medicine, National Academy of Inventors, American Institute for Medical and Biological Engineering, and the American Academy of Arts and Sciences. Ingber' Human Organ-on-a-Chip technology was named Design of the Year in 2015, honored as one of the Top 10 Emerging Technologies of 2016 by the World Economic Forum, and acquired by the Museum of Modern Art (MoMA) in New York City for its permanent collection.
No resources found.
No links found.